Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles
Kai-Wen Huang1, Shieh-Yueh Yang2,3, Yu-Wei Hong3, Jen-Jie Chieh3, Che-Chuan Yang3, Herng-Er Horng3, Chau-Chung Wu4, Chin-Yih Hong5, Hong-Chang Yang61Department of Surgery and Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University, Taipei, 2MagQu Co, Ltd, Sindian D...
Guardado en:
Autores principales: | Huang KW, Yang SY, Hong YW, Chieh JJ, Yang CC, Horng HE, Wu CC, Hong CY, Yang HC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6f132fbf43be43ae9cf76f958278defa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characteristics of magnetic labeling on liver tumors with anti-alpha-fetoprotein-mediated Fe3O4 magnetic nanoparticles
por: Huang KW, et al.
Publicado: (2012) -
Use of immunomagnetic reduction for C-reactive protein assay in clinical samples
por: Chang CH, et al.
Publicado: (2012) -
Alpha‐fetoprotein and focal nodular hyperplasia: An unconventional couple
por: Paul Carrier, et al.
Publicado: (2021) -
Alpha-fetoprotein–producing recurrent nasopharyngeal carcinoma: A case report
por: Zhen-Chong Yang, et al.
Publicado: (2021) -
Small cell neuroendocrine carcinoma expressing alpha fetoprotein in the endometrium
por: Hou Weiwei, et al.
Publicado: (2021)